Combining luteinising hormone releasing hormone agonists and aromatase inhibitors in breast cancer.
Krell
Jonathan
J
Ewart
Edwina K
EK
Stebbing
Justin
J
D000077384:Anastrozole; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000008:administration & dosage; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D017273:Goserelin / Q000008:administration & dosage; D006801:Humans; D007986:Luteinizing Hormone / Q000819:agonists*; D009570:Nitriles / Q000008:administration & dosage; D014230:Triazoles / Q000008:administration & dosage
D047072:Aromatase Inhibitors; D009570:Nitriles; D014230:Triazoles; D017273:Goserelin; D000077384:Anastrozole; D007986:Luteinizing Hormone